Oncoinvent ASA

Oncoinvent ASAverified

0RU5.L

Oncoinvent ASA engages in the development of biopharmaceutical product for cancer therapy. It focuses on developing a pipeline of AXL kinase inhibitors. Its lead product bemcentinib, is a selective and orally bio-available small molecule AXL inhibitor. The company was founded by James Bradley Lorens and David R. Micklem on December 21, 2007 and is headquartered in Bergen, Norway.

Industry

Medical - Pharmaceuticals

IPO Date

2017-12-13

Stock Exchange

LSE

Ticker

0RU5.L

The ROE as of December 2025 (TTM) for Oncoinvent ASA (0RU5.L) is -113.42%

According to Oncoinvent ASA’s latest financial reports and current stock price. The company's current ROE is -113.42%. This represents a change of 99.07% compared to the average of -56.98% of the last 4 quarters.

Oncoinvent ASA (0RU5.L) Historical ROE (quarterly & annually)

How has 0RU5.L ROE performed in the past?

The mean historical ROE of Oncoinvent ASA over the last ten years is -111.88%. The current -113.42% ROE has changed 1.38% with respect to the historical average. Over the past ten years (40 quarters), 0RU5.L's ROE was at its highest in in the June 2016 quarter at 0%. The ROE was at its lowest in in the December 2022 quarter at -152.70%.

Quarterly (TTM)
Annual

Average

-111.88%

Median

-87.71%

Minimum

-341.39%

Maximum

-38.35%

Oncoinvent ASA (0RU5.L) ROE by Quarter and Year

Discovering the peaks and valleys of Oncoinvent ASA ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 324.15%

Maximum Annual ROE = -38.35%

Minimum Annual Increase = -57.73%

Minimum Annual ROE = -341.39%

Quarterly (TTM)
Annual
YearROEChange
2024-113.51%-24.00%
2023-149.36%-56.25%
2022-341.39%324.15%
2021-80.49%109.85%
2020-38.35%-57.73%
2019-90.73%59.60%
2018-56.85%9.31%
2017-52.01%-38.59%
2016-84.69%-23.96%
2015-111.37%134.39%

Oncoinvent ASA (0RU5.L) Average ROE

How has 0RU5.L ROE performed in the past?

The current ROE of Oncoinvent ASA (0RU5.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-201.42%

5-year avg

-144.62%

10-year avg

-111.88%

Oncoinvent ASA (0RU5.L) ROE vs. Peers

How is 0RU5.L’s ROE compared to its peers?

Oncoinvent ASA’s ROE is greater than Arecor Therapeutics plc (-197.54%), less than Imugene Limited (0%), greater than Yext, Inc. (-127.46%), less than null (0%), less than null (17.50%),

CompanyROEMarket cap
-197.54%N/A
0%N/A
-127.46%$1.07B
0%N/A
17.50%N/A

Build a custom stock screener for Oncoinvent ASA (0RU5.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncoinvent ASA using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oncoinvent ASA (0RU5.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oncoinvent ASA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Oncoinvent ASA's ROE?

How is the ROE calculated for Oncoinvent ASA (0RU5.L)?

What is the highest ROE for Oncoinvent ASA (0RU5.L)?

What is the 3-year average ROE for Oncoinvent ASA (0RU5.L)?

What is the 5-year average ROE for Oncoinvent ASA (0RU5.L)?

How does the current ROE for Oncoinvent ASA (0RU5.L) compare to its historical average?